PCN117 Immune-related adverse events (irAEs) in NSCLC patients treated with programmed cell death 1 (PD-1) inhibitors: An analysis using the data from FDA adverse event reporting system (FAERS)
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.209
https://www.valueinhealthjournal.com/article/S1098-3015(21)00426-5/fulltext
Section Title :
Section Order :
10783
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00426-5&doi=10.1016/j.jval.2021.04.209